K. Verebey

发表

Carbon monoxide and thiocyanate levels in low tar/nicotine smokers

A. Stunkard, J. Jaffe, M. Kanzler, 1981 .

A rapid, quantitative GLC method for the simultaneous determination of nicotine and cotinine.

J. Jaffe, M. Kanzler, K. Verebey, 1982, Journal of analytical toxicology.

Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography.

K. Verebey, A. DePace, S. Mulé, 1977, Analytical chemistry.

Endorphins and Mental Disease

M. Gold, K. Verebey, 1985 .

Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing

J. Volavka, K. Verebey, S. Mulé, 1976, Clinical pharmacology and therapeutics.

Laboratory Testing in the Diagnosis of Marijuana Intoxication and Withdrawal

M. Gold, K. Verebey, S. Mulé, 1986 .

Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.

K. Verebey, S. Mulé, M. Kogan, 1977, Clinical chemistry.

From Coca Leaves to Crack: The Effects of Dose and Routes of Administration in Abuse Liability

M. Gold, K. Verebey, 1988 .

The Psychopharmacology of Cocaine

M. Gold, K. Verebey, 1984 .

The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.

K. Verebey, 1981, NIDA research monograph.

Opioids in mental illness: theories, clinical observations, and treatment possibilities.

K. Verebey, 1987, Annals of the New York Academy of Sciences.

Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene

G. Woody, W. Colburn, C. Inturrisi, 1982, Clinical pharmacology and therapeutics.

Qualitative differentiation between cocaine, lidocaine and cocaine-lidocaine mixtures ("rock-cocaine") using thin-layer chromatography.

K. Verebey, S. Mulé, D. Jukofsky, 1980, Journal of Chromatography A.

The complications of 'ecstasy' (MDMA)

J. Jaffe, K. Verebey, J. Alrazi, 1988, JAMA.

The Role of the Laboratory in the Diagnosis of LSD and Ecstasy Psychosis

R. Dupont, K. Verebey, 1994 .

Alcohol euphoria: possible mediation via endorphinergic mechanisms.

K. Blum, K. Verebey, 1979, Journal of psychedelic drugs.

Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.

K. Verebey, S. Mulé, 1975, The American journal of drug and alcohol abuse.

Phencyclidine-induced stereotypy in rats: Effects of methadone, apomorphine, and naloxone

K. Verebey, S. Mulé, M. Kogan, 2004, Psychopharmacology.

Endorphins in psychiatry: an overview and a hypothesis.

J. Volavka, K. Verebey, D. Clouet, 1978, Archives of general psychiatry.

Loss of the cortisol response to naltrexone in Alzheimer's disease

C. Tamminga, N. Pomara, M. Galloway, 1988, Biological Psychiatry.

Quantitative determination of naltrexone and betanaltrexol in human plasma using electron capture detection

K. Verebey, A. DePace, S. Mulé, 1976 .

Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography.

J. Volavka, K. Verebey, S. Mulé, 1980, Journal of analytical toxicology.

Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.

K. Verebey, S. Mulé, 1979, NIDA research monograph.

Simultaneous determination of nicotine and cotinine in human plasma by nitrogen detection gas-liquid chromatography.

K. Verebey, S. Mulé, M. Kogan, 1981, Journal of forensic sciences.

Quantitative determination of haloperidol in human plasma by high-performance liquid chromatography.

K. Verebey, D. Pierson, M. Kogan, 1983, Therapeutic drug monitoring.

Determination of 6-β-naltrexol and naltrexone by bonded-phase adsorption thin-layer chromatography

M. Lehrer, K. Verebey, S. Mulé, 1986 .

Quantitation of l-alpha-acetylmethadol and its metabolites in human serum by capillary gas-liquid chromatography and nitrogen detection.

K. Verebey, A. DePace, S. Mulé, 1985, Journal of chromatography.

Rapid confirmation of enzyme-multiplied immunoassay test (EMIT) for phencyclidine-positive urine samples with capillary gas chromatography-nitrogen-phosphorus detection.

K. Verebey, A. DePace, 1988, Journal of chromatography.

Filter paper-collected blood lead testing in children.

K. Verebey, 2000, Clinical chemistry.

Blood collection and analytical considerations in blood lead screening in children.

D. Schonfeld, J. Deutsch, K. Verebey, 1995, Clinical chemistry.

Rapid, sensitive micro blood lead analysis: a mass screening technique for lead poisoning.

B. Davidow, K. Verebey, A. Ramon, 1991, Journal of analytical toxicology.

A quick, qualitative assay for alcohol in urine.

K. Verebey, S. Mulé, 1986, Journal of analytical toxicology.

Cocaine Metabolite) in Human Urine

A. Pace, K. Verebey, S. Mulé, 1977 .

One hundred EMIT positive cannabinoid urine samples confirmed by BPA/TLC, RIA, and GC/MS.

M. Lehrer, K. Verebey, S. Mulé, 1986, Journal of analytical toxicology.

Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.

K. Verebey, 1981, NIDA research monograph.

Interpretation of drug abuse testing: strengths and limitations of current methodology.

M. Gold, K. Verebey, D. Martin, 1985, Psychiatric medicine.

Confirmation of EMIT benzodiazepine assay with GLC/NPD.

K. Verebey, S. Mulé, D. Jukofsky, 1982, Journal of analytical toxicology.

Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration.

K. Verebey, S. Mulé, M. Kogan, 1977, Research communications in chemical pathology and pharmacology.